Companies under Tsinghua Holdings continue to support COVID-19 prevention and control
2020-02-11
Many subsidiaries under Tsinghua Holdings are giving technologies and services as part of their ongoing support of the national efforts in prevention and control of the novel coronavirus pneumonia (COVID-19).
Efficient network and information systems offered for Leishenshan Hospital
Tsinghua Unigroup and its subsidiary H3C donated network communication and information security equipment to the rapidly-built Leishenshan Hospital to curb the spread of COVID-19. The project team efficiently completed equipment installation, commissioning and business docking tests to ensure the hospital’s information systems could be put into use as soon as possible.
Tsinghua Unigroup and H3C’s network communication and information security equipment is hard at work in Leishenshan Hospital.
With industry-leading wireless products and solutions, H3C provided high-quality wireless networks and will continue to provide 24/7 remote service support for the hospital.
Technical team members of H3C in Leishenshan Hospital, Wuhan city
Two medical workers of Dandong First Hospital depart to assist Wuhan
On February 9, two nurses from Dandong First Hospital under Chengzhi Holding Co., Ltd. joined the third batch of the medical support team of Liaoning province to join the frontline of the fight against the epidemic in Wuhan.
Medical workers of the Dandong First Hospital before departing for Wuhan on Feb 9
To date, Dandong First Hospital has dispatched seven medical workers, all backbone members of the hospital’s staff in respiratory, critical care and emergency treatment, in three groups to Hubei province.
Public safety innovator builds community platform for COVID-19 prevention and control
Immediately after the onset of the outbreak, Tsinghua University's Institute for Public Safety Research and Beijing GS Technology Co., Ltd. (GSAFETY) set up a real-time epidemic situation awareness and analysis system for the Wuhan Municipal Government's Emergency Command Center and the Chinese Center for Disease Control and Prevention.
In just one week, the system was quickly in use by the epidemic prevention commands and epidemic monitoring platforms of more than 16 provinces and 30 cities including Beijing, Hubei, Guangdong, and Hunan.
GSAFETY also developed a community platform for COVID-19 prevention and control, building a comprehensive data collection system covering individuals, communities, enterprises, and governments. It will provide services such as personal information reporting, community epidemic investigation, work resumption tracking, and city epidemic situation analysis.
Application interface of the Community Big Data Platform for COVID-19 Prevention and Control
A mobile phone-based application is developed for information collection, reporting, and analysis.
Unis Insight gives network support for hospitals in Chengdu and Chongqing
The Public Health Clinical Medical Center of Chengdu city, Southwest China’s Sichuan province, finished its second phase of reconstruction on Feb 8. Subsidiaries of Tsinghua Unigroup -- Unis Insight and H3C -- provided network communications and security equipment for the project to ensure smooth information transfer.
An intelligent video solution was applied to the project to provide clinicians with a remote view of patients in the isolation ward.
Unis Insight also worked with H3C by giving free network and security equipment as well as installation and commissioning services to medical institutions designated for COVID-19 treatment in Chongqing Municipality.
The new network and security system are in use in many of Chongqing’s hospitals, supporting fever clinics, isolation wards, and PCR laboratories.
CapitalBio MedLab selected as COVID-19 nucleic acid detection unit in Beijing
CapitalBio MedLab was selected as a COVID-19 Nucleic Acid Detection Units in Beijing, and will assist the Beijing Municipal Government in completing viral nucleic acid testing on suspected cases in the city as soon as possible.
Since the sudden outbreak of COVID-19, CapitalBio has been doing emergency research. It has developed a new isothermal amplification microfluidic pathogen nucleic acid detection chip system that can detect 19 kinds of common respiratory viruses including the novel coronavirus from samples of patients' pharyngeal swabs and sputum in 1.5 hours. It has helped quickly confirm infected cases and allowed for early treatment.
Isothermal amplification microfluidic pathogen nucleic acid detection chip system of CapitalBio Corporation
Medical and health big data platform helps with COVID-19 prevention and control
Interface of the medical health big data platform
Chengdu Tus-Digital Medical Technology Development Co., Ltd., a subsidiary of Tus-Holdings, has built a medical health big data platform for the real-time and full-scale collection and processing of medical data in Chengdu city. The platform has access to data of 51 hospitals in Chengdu’s Wuhou district and helps the district conduct real-time medical monitoring for epidemic prevention.
By tracking and analyzing patients with symptoms including fever, cough, and pneumonia as well as patients diagnosed with pneumonia and those who have had close contact with COVID-19 infected patients, the platform collects statistics which it analyzes and reports to governmental departments.
Over the past 15 days, the platform has tracked 4,089 people and investigated nearly 100 suspected patients.